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AbstrAct
Background Escherichia coli is an important aetiological 
agent of bovine mastitis worldwide.
Methods In this study, 82 E. coli from bovine mastitis milk 
samples from 49 farms were analysed for their genetic 
diversity using phylogenetic grouping and multilocus 
sequence typing. The isolates were examined by PCR 
for a selection of virulence factors (VFs). Antimicrobial 
susceptibility profiles were assessed using the disk 
diffusion method.
Results The most prevalent phylogroups were group 
B1 (41.5 per cent of the isolates) and group A (30.5 per 
cent). A variety of 35 different sequence types (STs) were 
identified, including ST1125 (11 per cent), ST58 (9.8 
per cent), ST10 (8.5 per cent) and ST88 (7.3 per cent). 
Aggregate VF scores (the number of unique VFs detected 
for each isolate) ranged from 1 to 3 for 63.4 per cent of 
the isolates and were at least 4 for 12.2 per cent. For 
24.4 per cent of the isolates, the score was 0. The three 
most frequent VFs were traT, fyuA and iutA. The majority 
(72 per cent) of the isolates harboured traT. The majority 
(68.3 per cent) of the isolates were fully susceptible to 
all antimicrobials tested, with 22 per cent resistant to 
ampicillin and 14.6 per cent to tetracycline. Resistance 
rates were low for gentamicin (3.7 per cent), amoxicillin/
clavulanic acid (2.4 per cent) and ceftiofur (1.2 per cent), 
respectively.
Conclusion Among the study’s sample population, E. coli 
strains were genotypically diverse, even in cows from the 
same farm, although some STs occurred more frequently 
than others. Susceptibility to clinically relevant compounds 
remained high.
IntRoduCtIon
Escherichia coli occurs in the digestive tract 
of human beings and animals as a non- 
pathogenic, commensal part of the normal 
gut flora; however, some E. coli types may 
cause gastrointestinal disease and a range of 
extraintestinal infections.1
Many pathogenic E.coli are distinguished 
from commensal strains due to specific viru-
lence features that increase their ability to 
cause disease in otherwise healthy individ-
uals. Among the pathogenic features, certain 
virulence factors (VFs) are characteristic of 
intestinal pathogenic E. coli (IPEC), which 
comprise well- described and important 
categories such as enteropathogenic E. coli 
(EPEC), Shiga toxin- producing E.coli (STEC), 
and its subgroup enterohaemorrhagic E. coli 
(EHEC), enteroaggregative E. coli (EAEC) or 
enterotoxigenic E. coli (ETEC).1–3
Other virulence attributes are associ-
ated with extraintestinal pathogenic E. coli 
(ExPEC), which encompass uropathogenic 
E. coli, newborn meningitis E. coli and avian 
pathogenic E. coli (APEC), which causes 
respiratory tract infections and septicaemia 
in poultry.1
In cattle, E. coli is an important aetiolog-
ical agent of mastitis, which is one of the 
most common and economically significant 
diseases in the dairy industry worldwide.4 
Bovine mastitis E. coli—unlike many other 
pathogenic E. coli—appears to lack consis-
tent genotypes and specific defining viru-
lence profiles, making a differentiation from 
commensal E. coli challenging.5–7 Previous 
studies show that virulence traits typically 
identified in IPEC or ExPEC are not account-
able for invasion and survival of E. coli inside 
mammary epithelial cells in vitro, nor do they 
appear to contribute to clinical severity of 
the disease.8 9 Bovine mastitis E. coli is gener-
ally thought to bear the same pathogenic 
potential as commensal or environmental E. 
coli.10 11 Nevertheless, some studies suggest 
that certain genotypes may be more prevalent 
among mastitis- associated E. coli compared 
with environmental strains.5 Therefore, 
further assessment of the genotypes of E. 
coli causing bovine mastitis is needed to fill 
current knowledge gaps.
Bovine mastitis is the most frequent reason 
for use of antimicrobials in dairy cattle.6 12 To 
promote the efficient and appropriate use 
of antimicrobials in veterinary medicine, the 
Swiss Veterinary Society (SVS), which is the 
official representing body of veterinarians, 
together with the Federal Food Safety and 
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Veterinary Office have issued guidelines that provide 
practical recommendations for the prescription and 
application of antimicrobials for treating livestock. The 
recommendations are in accordance with the Swiss law 
on pharmaceutical and medicinal products and with 
international Good Clinical Practice standards.13
For mastitis cases requiring treatment, the SVS guide-
lines recommend gentamicin as first- line antimicrobial 
agent for intramammary treatment in cases of bovine 
mastitis caused by E. coli, and fourth- generation ceph-
alosporins as second- line therapy.13 However, third- 
generation and fourth- generation cephalosporins belong 
to the highest priority critically important antimicrobials 
(HPCIA) for the use in human beings, and the emergence 
and global dissemination of antimicrobial resistance in 
general, and extended- spectrum ß-lactamase (ESBL) 
producing Enterobacteriaceae in particular, represent 
a threat to public health.14 ESBL producers have been 
described infrequently in E. coli isolated from bovine 
mastitis in Germany, France, Switzerland and the UK.15–18 
Further, a study from Germany found a prevalence of 
9.5 per cent ESBL- producing E. coli in bulk tank milk.19 
Therefore, current data on the antimicrobial suscepti-
bility profiles of bovine mastitis isolates are warranted.
The aims of the present study were to determine the 
genotypes and the virulence profiles of E. coli strains 
isolated from bovine mastitis, and to obtain data on their 
antimicrobial susceptibility profiles.
MateRIals and Methods
Bacterial isolation and species identification
In this study, a total of 82 non- duplicate E. coli strains 
were collected from 82 dairy cows with clinical mastitis 
on 49 different farms during 2017. The farms were 
customers of the ambulatory veterinary hospital of the 
University of Zürich that services the canton of Zürich 
and the surrounding region. The client population 
consists of approximately 124 cattle farms, whereof 60 
per cent are dairy farms. The average dairy herd size in 
the study region is 20–30 cows, and the most common 
dairy cow is the Brown Swiss. Clinical mastitis diagnosis 
was performed during farm calls by the veterinarian in 
charge according to a standardised procedure which 
included physical examination of the udder and the esti-
mation of the somatic cells in the milk using the Cali-
fornia mastitis test. Milk samples were taken from the 
affected quarter of each cow and were submitted to the 
routine mastitis diagnostic laboratory of the Institute for 
Food Safety and Hygiene in Zürich. Overall, during the 
study period, a total of 1281 milk samples from the farms 
in the client population were submitted for culture to the 
diagnostic laboratory. From samples yielding microbial 
growth, the range of pathogens identified as the cause 
of mastitis included staphylococci (16.6 per cent), Staph-
ylococcus aureus (7 per cent), Streptococcus uberis (12.6 per 
cent), Streptococcus dysgalactiae (3 per cent), E. coli (11.9 
per cent) and other pathogens (10 per cent).
Samples were cultured according to standard proce-
dures.20 Briefly, using a sterile loop, the samples were 
streaked onto sheep blood agar base (Becton Dickinson, 
Allschwil, Switzerland), supplemented with 5 per cent 
sheep blood (Oxoid, Pratteln, Switzerland) and incu-
bated at 37°C overnight. The strains were confirmed by 
colony morphology, Gram stain, and biochemical tests 
such as the mannitol fermentation test, O- nitrophenyl- 
beta- D- galactopyranoside (ONPG) test, tests for urease, 
indole and hydrogen sulfide (H2S) production, and 
the lysine decarboxylase test. The strains were stored at 
–80°C.
Phylogenetic and multilocus sequence typing
DNA from E. coli isolates was subjected to quadruplex 
PCR targeting arpA, chuA, yjaA and an unspecified DNA 
fragment termed TspE4.C2, as described previously.21 
The isolates were classified as belonging to one of the 
eight phylogenetic groups A, B1, B2, C, D, E, F (E. coli 
sensu stricto), or Escherichia clade I.
For multilocus sequence typing (MLST), internal 
fragments of the seven housekeeping genes (adk, fumC, 
gyrB, icd, mdh, purA and recA) were amplified by PCR as 
described by Wirth and colleagues.22 Sequencing of the 
amplification products was performed by Microsynth 
(Balgach). Sequences were imported into the E. coli MLST 
database website (https:// pubmlst. org/ escherichia/) to 
determine MLST types. Alleles and sequence types (STs) 
that had not been previously described were designated 
‘new ST’, but not assigned numerical designations, since 
whole- genome sequencing was not performed. Data were 
visualised using the platform independent JAVA software 
Phyloviz 2.0 and the goeBURST algorithm.23
Virulence factor determination
All 82 isolates were screened for genetic markers of viru-
lence associated with ExPEC by conventional PCR using 
primers and conditions described previously for targeting 
afa, papAH, papC, papEF, sfaS, fyuA, hlyA, iutA, KpsMII, 
PAI and traT,24 vat and yfcV.25 The aggregate VF score was 
defined as the number of unique VF detected for each 
isolate, counting the PAI marker as one.
Strains were further screened by PCR for genetic 
markers characterising IPEC. Screening for stx1 and stx2 
genes in STEC was performed by real- time PCR (Light-
Cycler 2.0 Instrument, Roche Diagnostics Corporation, 
Indianapolis, Indiana, USA) using the QuantiFast Multi-
plex PCR Kit (Qiagen, Hombrechtikon, Switzerland) 
according to the guidelines of the European Union 
Reference Laboratory (EURL).26 The determination 
of stx1 subtypes was performed by conventional PCR 
amplification.27
The presence of subAB encoding subtilase cytotoxin 
SubAB was tested by conventional PCR using primers 
described previously.28
Screening for the intimin gene eae in EPEC, and for 
the heat- labile and heat- stabile enterotoxins LT, STp and 
STh in ETEC, was performed by real- time PCR according 
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to the guidelines of the EURL.29 30 Screening for aggR, 
which encodes a transcriptional regulator of EAEC, 
was performed by conventional PCR using primers and 
conditions described previously.31
For all PCR assays, DNA from previously characterised 
isolates from the authors’ strain collection was used as 
positive or negative controls for strains harbouring VFs 
associated with ExPEC32 33 and VFs characteristic of 
IPEC.32 34 35
antimicrobial susceptibility testing
The strains were subjected to antimicrobial susceptibility 
testing (AST) using the standard disk diffusion method 
according to the protocols recommended by the Clin-
ical and Laboratory Standards Institute (CLSI),36 which 
is currently the only committee offering interpretive 
criteria for veterinary AST.37 The isolates were classified 
as susceptible, intermediate or resistant using the break-
points listed by the VET01S of the CLSI.38 Multidrug 
resistance (MDR) was defined as resistance to three or 
more classes of antimicrobials, counting ß-lactams as one.
Susceptibility disks containing ampicillin (AM), amoxi-
cillin/clavulanic acid (AMC), tetracycline (TE) and sulfa-
methoxazole/trimethoprim (SXT) were obtained from 
Becton Dickinson, and disks containing ceftiofur (EFT) 
and gentamicin (CN) were from Thermo Fisher Diagnos-
tics (Pratteln, Switzerland). E. coli ATCC 25922 was used 
as a control during AST.
The antibiotics were chosen on the basis of their recom-
mendations for intramammary application in Switzer-
land and of the panel included in the German national 
antibiotic resistance monitoring of veterinary pathogens 
from cattle (GermVet).13 39
To test for the presence of ESBL- producing E. coli, the 
isolates were cultured on Brilliance ESBL agar plates 
(Oxoid, Hampshire, UK) and incubated for 24 hours at 
37°C.
Results
Bacterial isolates and herd data
For this study, a total of 82 E. coli strains originating 
from 82 different animals from 49 different herds were 
obtained. Twelve (24.5 per cent) of the herds were 
sampled more than once, whereby each sample derived 
from a case of mastitis diagnosed by the veterinarian in 
charge. The highest numbers of E. coli mastitis cases per 
farm were eight cases on farm F8 and F16, respectively, 
and seven cases on farm F14 (online supplementary table 
S1). Acute mastitis was diagnosed in 66 cases, subclinical 
in two cases and chronic mastitis in one case, respectively. 
For 13 cases, the type of mastitis was unspecified (online 
supplementary table S1).
Phylogenetic groups, sts and VF distribution
Of the 82 E. coli isolates, 34 (41.5 per cent) belonged to 
phylogenetic group B1, followed by group A (n=25; 30.5 
per cent), C (n=9; 11 per cent) and D (n=8; 9.8 per cent). 
The remaining isolates (n=2; 2.4 per cent each) belonged 
to phylogenetic groups B2, E and F (table 1 and online 
supplementary table S1).
MLST identified 35 different STs, the four most 
common represented by ST1125 (n=9; 11 per cent of the 
isolates), ST58 (n=8; 9.8 per cent), ST10 (n=7; 8.5 per 
cent) and ST88 (n=6; 7.3 per cent). Twenty- one (26 per 
cent) of the isolates belonged to STs that occurred only 
once. Five (6 per cent) of the isolates belonged to human 
ExPEC lineages ST69 or ST117 (online supplementary 
table S1). Seven (8.5 per cent) of the isolates belonged 
to STs with a total of five new allelic profiles (online 
supplementary table S1). The new STs were not assigned 
numerical designations by the E. coli MLST database. 
Further, two isolates could not be typed due to failure to 
sequence the purA gene. The goeBURST analysis of the 
strains is shown in figure 1.
On farms with multiple cases of mastitis, various STs 
were observed. On farms F8 and F16 (eight individual 
cases of E. coli mastitis each), a total of seven STs and on 
farm F14 (seven cases of mastitis) four different STs were 
noted (online supplementary table S1).
Among the 82 isolates, the prevalence of individual 
ExPEC associated VFs ranged from 0 per cent (afa and 
sfa, respectively) to 72 per cent (traT).
The frequency of VFs among the phylogenetic groups 
is shown in table 1. Median aggregate VF scores were 
highest for isolates belonging to phylogenetic group B2 
(median VF score 5, range 2–8) and group F (median 
VF score 4, range 4–4); however, these two groups only 
included two isolates each. Median aggregate VF scores 
were lower for isolates belonging to phylogroup D 
(median VF score 0.5, range 0–3).
The distribution of VFs among the most frequently 
occurring STs is summarised in table 2. Median aggre-
gate VF scores were highest for isolates belonging to 
ST58 (median VF score 3, range 1–5) and ST88 (median 
VF score 3, range 0–5), and low for isolates belonging 
to ST1125 (median VF score 2, range 2–2) and ST10 
(median VF score 1, range 0–1). For all other STs, the 
median VF score was 1, with a range of 0–8 (table 2). 
Among these, one isolate with a new ST scored a VF 
factor of 8 (online supplementary table S1). The diversity 
of VF scores among all the isolates analysed in this study 
is illustrated in figure 1.
IPEC- associated VFs stx1a and subAB were detected in 
two (2.4 per cent) and one (1.2 per cent) of the isolates, 
respectively (table 1). None of strains tested positive for 
aggR, afa, eae, LT, sfa, STh, STp or stx2.
antimicrobial susceptibility testing
The prevalence of resistant, intermediate and suscep-
tible strains among the bovine mastitis E. coli isolates 
is summarised in figure 2. Overall, the majority (n=56; 
68.3 per cent) of the isolates were fully susceptible to all 
antimicrobials tested in this study (online supplementary 
table S1). The highest rate of resistance was observed 
for AM (n=18; 22 per cent), followed by TE (n=12; 14.6 
per cent), SXT (n=8; 9.8 per cent) and CN (n=3; 3.7 per 
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Table 1 Distribution of virulence factors among the phylogenetic groups of 82 Escherichia coli causing bovine mastitis
Gene or marker*
Prevalence by phylogenetic group (n, %)
A B1 B2 C D E F
(n=25) (n=34) (n=2) (n=9) (n=8) (n=2) (n=2)
ExPEC- associated genes
  papAH 2 (8.0) 2 (5.9) – 3 (33.3) – – –
  papC 2 (8.0) 2 (5.9) – 3 (33.3) – – –
  papEF – – – 1 (11.1) – – –
  yfcv – – 2 (100) – – –
  hlyA 1 (4.0) 12 (35.3) 1 (50) – 1 (12.5) – –
  vat 1 (50) – – – 2 (100)
  fyuA 6 (24.0) 8 (23.5) 1 (50) 6 (66.7) – – 2 (100)
  iutA 3 (12.0) 5 (14.7) 1 (50) 5 (55.6) 1 (12.5) – 2 (100)
  KpsMII – – 1 (50) – 1 (12.5) – –
  PAI – – 1 (50) – – – –
  traT 14 (56.0) 27 (79.4) 2 (100) 8 (88.9) 4 (50) 2 (100) 2 (100)
  Virulence factor score 
(median, range)
1, 0–4 2, 0–5 5, 2–8 3, 0–6 0.5, 0–3 1, 1–1 4, 4–4
IPEC- associated genes
  stx1a 2 (8.0) – – – – – –
  subAB – 1 (2.9) – – – – –
*aggR, afa, eae, LT, sfa, STh, STp and stx2 genes were not identified in any of the isolates.
–, not detected; ExPEC, extraintestinal pathogenic E. coli;fyuA, ferric yersiniabactin uptake protein; hlyA, haemolysin; IPEC, intestinal 
pathogenic E. coli; iutA, aerobactin siderophore receptor; KpsMII, group 2 polysaccharide capsule; PAI, right- hand terminus of pathogenicity 
island; papAH, pyelonephritis- associated major pilin protein; papC, outer membrane usher protein; papEF, fimbrial protein subunit; stx1a, 
Shiga toxin subunit; subAB, subtilase cytotoxin; traT, lipoprotein involved in serum resistance; vat, vacuolating autotransporter toxin; yfcv, 
major subunit of a chaperone- usher fimbria.
cent). Resistance rates were low for AMC (n=2; 2.4 per 
cent) and EFT (n=1; 1.2 per cent), respectively. Notably, 
for EFT, seven strains were categorised intermediate 
resistant (figure 2). Eight strains (9.8 per cent) were 
resistant to three or more classes of antibiotics (MDR). 
The MDR phenotype AM/TE/SXT represented the most 
common pattern (six isolates), followed by AM/AMC/
CN/TE and AM/CN/TE/SXT (one isolate each, respec-
tively).
The prevalence of antimicrobial resistance was high 
among isolates belonging to ST58 and ST88 and low 
among ST10 and ST1125 (table 3). Among the remaining 
STs, antimicrobial resistance was found predominantly 
among ST117 and ST167, respectively (online supple-
mentary table S1).
None of the E. coliisolates yielded growth on ESBL 
plates.
.
dIsCussIon
Bovine mastitis caused by E. coli is generally consid-
ered to include typically commensal strains of intes-
tinal or environmental origin.40 41 Commensal strains 
have been shown by phylogenetic analyses to position 
within phylogenetic groups A, B1 or C, while virulent 
extraintestinal E. coli strains belong mainly to group B2, 
and to a lesser extent to groups D, E or F.21
In line with previous reports,5 6 10 42 the isolates from 
the present study were mainly of phylogenetic groups 
A and B1, with the exception of isolates belonging to 
phylogroup C, which were not identified in earlier studies 
that restricted classifications to four main phylogenetic 
groups A, B1, B2 and D.43 Phylogroup C is closely related 
to group B1, but before its recognition as a distinct 
phylogroup its members were classified within group A.44 
Consequently, the prevalence of phylogroup A mastitis 
strains may have been overestimated in the past.45 Further-
more, mastitis isolates belonging to phylogroups E and 
F were detected in the current study. While phylogroup 
F comprises strains that were formerly classified group 
D, phylogroup E includes a small number of E.coli, to 
which EHEC O157:H7 and its ancestor O55:H7 belong.21 
Similar to previously described mastitis strains belonging 
to phylogroup F, both isolates in the current study lacked 
virulence traits that characterise EHEC strains, and their 
significance among mastitis isolates, although remark-
able, remains unclear.46
In agreement with previous studies that document the 
absence of specific genotypes to characterise mastitis E. 
coli, a wide variety of STs were observed, indicating high 
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Figure 1 MLST- based minimal spanning tree of 82 
Escherichia coli isolated from bovine mastitis milk in 
Switzerland during 2017. The tree was calculated and 
generated using the goeBURST full MLST algorithm in 
Phyloviz 2.0. Node sizes reflect the number of isolates with 
specific MLST profile. Numbers within the nodes indicate 
the ST. Founder STs are encircled in yellow. Node colours 
refer to virulence scores within an ST. Nodes differing by 
one or two loci are linked by dark lines. M1, strains with 
incomplete profiles (the missing purA allele was treated as 
an own category); U1–U5, strains with new STs. New STs 
were not assigned numerical designations by the E. coli 
MLST database (https://pubmlst.org/escherichia/). MLST, 
multilocus sequence typing; ST, sequence type; VF, virulence 
factor.
heterogeneity.6 7 10 Even most isolates from multiple cows 
on the same farms displayed diverse STs, with a maximum 
of two isolates from any one farm belonging to the same 
ST. Nevertheless, E. coli ST10, ST58 and ST1125, which 
were among the most common STs from this collection 
of isolates, were also frequent among mastitis strains 
isolated previously in Israel.5 E. coli ST1125 has also been 
described among mastitis strains from cattle in Germany 
and Ireland.11 47 Taken together, these findings indicate 
that notwithstanding the high genetic variability, certain 
STs may predominate among bovine mastitis strains. E. 
coli ST10, which occurs frequently among livestock, food 
and healthy human beings, is significantly more preva-
lent among mastitis isolates compared with environ-
mental isolates.5 32 ST58 and ST88, although also isolated 
globally from a wide variety of sources, may cause disease 
in human beings, including urinary tract infection and 
sepsis.48 49 Several STs less frequently identified in this 
study have also been described among human clinical 
isolates, diseased animals and livestock, and represent 
typical ExPEC. For instance, E. coli ST69, isolated from 
three mastitis cases in this study, is accountable for 
community- acquired and healthcare- associated urinary 
tract infections worldwide,50 and E. coli ST117, detected 
in two cases, has been identified among APEC strains 
causing colibacillosis in broilers.51 52 Nevertheless, an 
association of these STs with severity of mastitis was not 
investigated, which may be considered a limitation of 
this study. Interestingly, E. coli ST69 was recently identi-
fied in faecal samples of dairy cows in Washington state 
in USA, and in raw milk cheese in Egypt, suggesting that 
this pandemic human disease- associated ST may be circu-
lating in dairy cattle worldwide.53 54
Although the pathogenesis mechanisms of many E. coli 
genotypes are well described for other epithelial systems, 
VFs enabling adherence and survival within the bovine 
mammary gland remain, to a large extent, undefined.55 56 
In the present study, traT was the only VF to characterise 
the majority (72 per cent) of the strains. This plasmid- 
located determinant encodes an outer membrane 
protein thought to block the membrane attack complex 
present in the serum of the host.57 Although serum resis-
tance has repeatedly been reported in E. coli mastitis 
isolates, it is currently considered to be an unspecific 
feature of mastitis isolates.58 Therefore, although the 
traT gene is prevalent among human, avian and porcine 
ExPEC,24 59 60 and has also been described in mastitis E. 
coli in previous studies, the significance of traT among 
mastitis E. coli remains unclear.58 61 In addition to traT, 
only two other VFs, fyuA and iutA, were found to be prev-
alent among the isolates from this study. Both genes 
encode ferric acquisition proteins that allow bacteria to 
grow in environments with limited concentrations of free 
iron, such as in tissues and fluids of the host.62 The fyuA 
gene encodes a ferric yersiniabactin uptake protein and 
is strongly associated with uropathogenicity in human 
beings.25 It has been suggested that the presence of fyuA 
is not essential for survival of E. coli in mammary glands, 
but that its presence may contribute to the ability to 
utilise iron from lactoferrin, one of the main iron sources 
available to bacteria in milk.63 Similarly, iutA, encoding 
for an aerobactin receptor, is frequently associated 
with ExPEC but not, so far, with mastitis strains.40 62 In 
this study, a limited number of VF genes were analysed. 
Despite this constraint, the wide variation of aggregate 
VF scores among the phylogenetically diverse strains in 
this study lends support to previous data that there exists 
no distinct bovine mastitis E. coli pathotype.40
The prevalence of IPEC- associated virulence genes 
was low among the isolates, which is remarkable because 
cattle are considered a major reservoir for EPEC, STEC 
and EHEC.64 65 Moreover, a recent study evaluating 
the global prevalence of STEC in bovine mastitis cases 
estimated that in Europe, STEC occurs in 0.5–13.7 per 
cent of mastitic milk, and suggested that the prevalence 
of STEC in mastitis may be underestimated.66 Only two 
(2.4 per cent) of the isolates in the present study, both 
belonging to phylogenetic group A and ST730, were 
stx1a- positive, and they did not encode the intimin gene 
eae. Interestingly, the occurrence of subAB in an isolate 
that did not contain stx1 or stx2 was observed. This is one 
of very few reports of non- STEC harbouring subAB.67
Overall, these data show that susceptibility to anti-
microbials remains high among the study’s sample 
population of mastitis E.coli in Switzerland. Utmost 
caution should be applied when comparing AST results 
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Table 2 Distribution of virulence factors among four main sequence types of 82 Escherichia coli causing bovine mastitis
Gene or marker*
Prevalence by sequence type (n, %)
ST10 ST58 ST88 ST1125 Other
(n=7) (n=8) (n=6) (n=9) (n=52)
ExPEC- associated genes
  papAH – 2 (25) 2 (33.3) – 3 (5.8)
  papC – 2 (25) 2 (33.3) – 3 (5.8)
  papEF – – – – 1 (1.9)
  yfcv – – – – 2 (3.8)
  hlyA – – – 9 (100) 6 (11.5)
  vat – – – – 3 (5.8)
  fyuA 3 (42.9) 6 (75) 5 (83.3) – 9 (17.3)
  iutA – 5 (62.5) 4 (66.7) – 8 (15.4)
  KpsMII – – – – 2 (3.8)
  PAI – – – – 1 (1.9)
  traT 2 (29.6) 8 (100) 5 (83.3) 9 (100) 35 (67.3)
  Virulence factor score (median, 
range)
1, 0–1 3, 1–5 3, 0–5 2, 2–2 1, 0–8
IPEC- associated genes
  stx1a – – – – 2 (3.8)
  subAB – – – – 1 (1.9)
*aggR, afa, eae, LT, sfa, STh, STp and stx2 genes were not identified in any of the isolates.
–, not detected; ExPEC, extraintestinal pathogenic E. coli;fyuA, ferric yersiniabactin uptake protein; hlyA, haemolysin; IPEC, intestinal 
pathogenic E. coli; iutA, aerobactin siderophore receptor; KpsMII, group two polysaccharide capsule; PAI, right- hand terminus of 
pathogenicity island; papAH, pyelonephritis- associated major pilin protein; papC, outer membrane usher protein; papEF, fimbrial 
protein subunit; stx1a, Shiga toxin subunit; subAB, subtilase cytotoxin; traT, lipoprotein involved in serum resistance; vat, vacuolating 
autotransporter toxin; yfcv, major subunit of a chaperone- usher fimbria.
Figure 2 Antimicrobial susceptibility percentages among 82 Escherichia coli isolated from bovine mastitis milk in Switzerland 
during 2017. AM, ampicillin; AMC, amoxicillin/clavulanic acid; CN, gentamicin; EFT, ceftiofur; I, intermediate; R, resistant; S, 
susceptible; SXT, sulfamethoxazole/trimethoprim; TE, tetracycline.
obtained across different strain collections, countries 
and settings.68 A comparison with earlier data from Swit-
zerland obtained using identical methodologies and 
interpretive criteria showed no major shift in antibiotic 
resistance.16 Moreover, using identical CLSI interpreta-
tion criteria, resistance data from this study are similar 
to those from the German antimicrobial resistance moni-
toring programme GermVet, with the exception of EFT.39 
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Table 3 Distribution of antimicrobial resistance among four main sequence types of 82 Escherichia coli causing bovine 
mastitis
Resistance*
Prevalence by sequence type (n, %)
ST10 ST58 ST88 ST1125 Other
(n=7) (n=8) (n=6) (n=9) (n=52)
AM – 4 (50.0) 3 (50.0) 1 (11.1) 10 (19.2)
AMC – 1 (12.5) 1 (16.7) – –
EFT 1 (14.3) – – – –
CN – 2 (25.0) 1 (16.7) – –
TE – 4 (50.0) 1 (16.7) – 7 (13.5)
SXT – 3 (37.5) 1 (16.7) – 4 (7.7)
MDR – 3 (37.5) 1 (16.7) – 4 (7.7)
*Antimicrobial susceptibility was determined using the disk diffusion method according to the Clinical and Laboratory Standards Institute 
guidelines and breakpoints.36
–, no resistance detected; AM, ampicillin; AMC, amoxicillin/clavulanic acid; CN, gentamicin; EFT, ceftiofur; MDR, multidrug resistant (resistant 
to three or more classes of antimicrobials); SXT, sulfamethoxazole/trimethoprim; TE, tetracycline.
Regarding this antimicrobial, a lower rate of resistance 
compared with that reported by GermVet for the year 
2016 was identified (1.2 per cent v 7.6 per cent). Notably, 
in the study presented here, seven (8.5 per cent) of the 
isolates were categorised intermediate resistant. This may 
be indicative of a shift towards a resistant phenotype and 
warrants future observation. An increase of resistance to 
EFT from 0.4 per cent in 2006 to 2.4 per cent in 2016 has 
been reported for mastitis isolates in France.69 By contrast, 
resistance rates among mastitis isolates are reportedly low 
in other countries, for example, Denmark,70 with resis-
tance to AM reported in only 11.3 per cent and resistance 
to EFT and CN in 0 per cent of E. coli mastitis, respec-
tively. Given that EFT is among the category of HPCIA, 
it is crucial that this antimicrobial should only be used 
as a last resort, and first- line antimicrobial drugs should 
remain the treatment of choice.
Of the antimicrobials tested, EFT is the only one with 
a defined breakpoint for E. coli isolated from bovine 
mastitis.38 It is therefore important to note that the AST 
results for the other antimicrobials were interpreted using 
breakpoints relevant for the administration in human 
beings and thus may not be reflective of susceptibility, or 
be clinically predictive, in the context of bovine mastitis. 
Nevertheless, the results presented here provide a means 
by which to monitor trends in antimicrobial susceptibility 
and to identify emerging resistance. To this end, quanti-
tative data, such as the zone diameter measures provided 
in online supplementary table S1, could be helpful. 
Finally, this study emphasises the need for veterinary clin-
ical breakpoints to improve surveillance data, optimise 
treatment of animal disease and promote prudent anti-
microbial use.
ConClusIons
This work represents a study exploring the phenotypic 
and genotypic traits of E. coli involved in mastitis in Swiss 
dairy cows. The results highlight the clonal diversity of 
the isolates and suggest that certain STs such as ST58, 
ST88 and ST1125 may be more successful than others 
at colonising and infecting the mammary gland. Only 
a minority of the isolates represented typical ExPEC. 
Although no distinct virulence gene profile was detected 
among the isolates, traT was found in the majority of 
bovine E. coli mastitis cases. Therefore, traT may repre-
sent a virulence trait that favours pathogenesis in the 
bovine udder. Overall, antimicrobial susceptibility was 
high for ß-lactams, CN, TE and SXT. Moreover, no ESBL- 
producing E. coli were detected.
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